Switching monoamine oxidase inhibitors

Drug Intell Clin Pharm. 1985 Nov;19(11):825-7. doi: 10.1177/106002808501901105.

Abstract

Substituting one monoamine oxidase inhibitor for another is recommended only after a drug-free interval to avoid hypertensive emergencies. The evidence and mechanism firmly supporting this caution is lacking. We report a case where monoamine oxidase inhibitors were substituted without apparent adverse consequences.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Depressive Disorder / drug therapy
  • Humans
  • Lithium / adverse effects
  • Lithium / therapeutic use
  • Male
  • Monoamine Oxidase Inhibitors / adverse effects*
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Phenelzine / adverse effects*
  • Phenelzine / therapeutic use
  • Tranylcypromine / adverse effects
  • Tranylcypromine / therapeutic use

Substances

  • Monoamine Oxidase Inhibitors
  • Tranylcypromine
  • Lithium
  • Phenelzine